Pandor A - Search Results

1

Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.

Stevenson M, Pandor A. Stevenson M, et al. Among authors: pandor a. Health Technol Assess. 2009 Oct;13 Suppl 3:37-42. doi: 10.3310/hta13suppl3/06. Health Technol Assess. 2009. PMID: 19846027 Free article. Review.

2

Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.

Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Pandor A, et al. Health Technol Assess. 2004 Mar;8(12):iii, 1-121. doi: 10.3310/hta8120. Health Technol Assess. 2004. PMID: 14982654 Free article. Review.

3

Economics of tandem mass spectrometry screening of neonatal inherited disorders.

Pandor A, Eastham J, Chilcott J, Paisley S, Beverley C. Pandor A, et al. Int J Technol Assess Health Care. 2006 Summer;22(3):321-6. doi: 10.1017/s026646230605121x. Int J Technol Assess Health Care. 2006. PMID: 16984060 Free article. Review.

4

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.

Eggington S, Tappenden P, Pandor A, Paisley S, Saunders M, Seymour M, Sutcliffe P, Chilcott J. Eggington S, et al. Among authors: pandor a. Br J Cancer. 2006 Nov 6;95(9):1195-201. doi: 10.1038/sj.bjc.6603348. Epub 2006 Oct 10. Br J Cancer. 2006. PMID: 17031407 Free PMC article. Review.

5

The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P. Pandor A, et al. Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv, 1-185. doi: 10.3310/hta10410. Health Technol Assess. 2006. PMID: 17049138 Free article. Review.

6

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N. Ward S, et al. Among authors: pandor a. Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140. Health Technol Assess. 2007. PMID: 17408535 Free article. Review.

7

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J. Ara R, et al. Among authors: pandor a. Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. doi: 10.3310/hta12210. Health Technol Assess. 2008. PMID: 18485273 Free article. Review.

8

Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation.

Ara R, Pandor A, Stevens J, Rees A, Rafia R. Ara R, et al. Among authors: pandor a. Health Technol Assess. 2009 Jul;13(34):1-74, 75-118. doi: 10.3310/hta13340. Health Technol Assess. 2009. PMID: 19604457 Free article. Review.

9

Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.

Whyte S, Pandor A, Stevenson M, Rees A. Whyte S, et al. Among authors: pandor a. Health Technol Assess. 2010 Oct;14(Suppl. 2):47-53. doi: 10.3310/hta14suppl2/07. Health Technol Assess. 2010. PMID: 21047491 Free article. Review.

10

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.

Stevenson M, Pandor A. Stevenson M, et al. Among authors: pandor a. Pharmacoeconomics. 2011 Feb;29(2):133-40. doi: 10.2165/11535770-000000000-00000. Pharmacoeconomics. 2011. PMID: 21155617 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters